NCT05558800 is a NA clinical trial of Implant placement in Implant Geometry, sponsored by Saint-Joseph University.

Who is sponsoring NCT05558800?

NCT05558800 is sponsored by Saint-Joseph University.

What drugs are being tested in NCT05558800?

Interventions in NCT05558800: Implant placement.

What condition does NCT05558800 study?

NCT05558800 studies Implant Geometry.

Is NCT05558800 still recruiting?

NCT05558800 is currently completed. Last updated 30 November 2023.

Last reviewed 2023-11-30 · How we verify

NCT05558800

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bone-To-Implant Contact At 4- And 6-Week Healing Stages in Implants With Different Surfaces.

Completed NA Last updated 30 November 2023

What this trial tests

NA trial testing Implant placement in Implant Geometry in 11 participants. Completed in 30 July 2022.

Timeline

1 January 2018

Primary endpoint
30 July 2022

30 July 2022

Quick facts

Lead sponsor	Saint-Joseph University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	triple
Primary purpose	treatment
Enrollment	11
Start date	1 January 2018
Primary completion	30 July 2022
Estimated completion	30 July 2022
Sites	1 location across Lebanon

Drugs / interventions tested

Implant placement

Conditions studied

Implant Geometry — all drugs for Implant Geometry →

Sponsor

Saint-Joseph University

Who can join

18 and older, any sex, with Implant Geometry. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: Implant surface topography is a key element in achieving osseointegration. Nanostructured surfaces have shown promising results in accelerating and improving bone healing around dental implants. The main objective of the present clinical study is to compare, at 4 and 6w, bone-to-implant contact in implants having either machined surface (MAC), SLA medium roughness surface or a Nanostructured Calcium-Incorporated surface (XPEED®). Thirty five mini-implants with 3 different surface treatments (XPEED® (n=16) - SLA (n=13) - Machined (n=6)), were placed in the posterior maxilla of 11 patients then retrieved at either 4 or 6w in a randomized split-mouth study design.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Implant placement

Trials testing the same drug.

NCT06100120 — A Triple-blinded Non-inferiority Multicentre Randomized Controlled Trial Comparing Hybrid and Fully Etched Implants P1 · NA · unknown
NCT05847907 — RCT KS-SA Versur KS-BA in Diabetic Patients · NA · not yet recruiting
NCT06970184 — Alveolar Ridge Preservation With Cortico-cancellous Porcine Bone · active not recruiting
NCT04532359 — Measurement of Implant Stability by Resonance Frequency Analysis in Patients Treated for an Upper Aero-digestive Tract C · unknown
NCT05912725 — Conventional Impressions Versus Digital Impression Techniques for Implant Supported Screw Retained Prosthesis · NA · completed

Other Saint-Joseph University trials

Trials by the same sponsor.

NCT07449884 — AI Avatar Video vs. Tell-Show-Do for Reducing Anxiety and Improving Cooperation in Children During Local Anesthesia · NA · recruiting
NCT07350746 — A Comparison of Outcome of Pulpotomy on Immature Permanent Molars Between Different Calcium Silicate-based Materials : a · NA · active not recruiting
NCT07082283 — Short-Term Atrial Pacing and Hemodynamics After Cardiac Surgery · NA · recruiting
NCT07517601 — Erbium-doped Yttrium Aluminum Garnet (Er:YAG) Laser vs Conventional Ceramic Bracket Debonding: A Split-Mouth Clinical Tr · NA · active not recruiting
NCT07525128 — Lateral GBR Using Two Types of Membrane With a Combination of Allograft-xenograft · Phase 4 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05558800 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Saint-Joseph University
Last refreshed: 30 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05558800.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing